Search hospitals > Connecticut > New Haven
Yale University School of Medicine
Claim this profileNew Haven, Connecticut 06510
Global Leader in Alzheimer's Disease
Global Leader in Type 1 Diabetes
Conducts research for Diabetes
Conducts research for Cancer
Conducts research for Obesity
728 reported clinical trials
64 medical researchers
Summary
Yale University School of Medicine is a medical facility located in New Haven, Connecticut. This center is recognized for care of Alzheimer's Disease, Type 1 Diabetes, Diabetes, Cancer, Obesity and other specialties. Yale University School of Medicine is involved with conducting 728 clinical trials across 652 conditions. There are 64 research doctors associated with this hospital, such as Patricia M Lorusso, Alessandro Santin, Amer M. Zeidan, and Charles Matouk.Area of expertise
1Alzheimer's Disease
Global LeaderPSEN2 positive
PSEN1 positive
APP positive
2Type 1 Diabetes
Global LeadermIAA positive
IA-2A positive
ZnT8A positive
Top PIs
Patricia M LorussoYale Cancer Center1 year of reported clinical research
Expert in Tumors
Studies Solid Tumors
21 reported clinical trials
37 drugs studied
Alessandro SantinSmilow Cancer Hospital at Yale New Haven4 years of reported clinical research
Studies Ovarian Cancer
Studies Ovarian Tumors
15 reported clinical trials
24 drugs studied
Amer M. ZeidanYale Cancer Center3 years of reported clinical research
Studies Leukemia
Studies Myelodysplastic Syndrome
14 reported clinical trials
23 drugs studied
Charles MatoukYale University5 years of reported clinical research
Studies Stroke
Studies Brain Aneurysm
12 reported clinical trials
11 drugs studied
Clinical Trials running at Yale University School of Medicine
Tumors
Non-Small Cell Lung Cancer
Multiple Myeloma
Solid Tumors
Cancer
Plasma Cell Neoplasms
Alzheimer's Disease
Non-Hodgkin's Lymphoma
Opioid Use Disorder
Migraine
BI 1703880 + Ezabenlimab
for Advanced Solid Tumors
This study is open to adults with different types of advanced cancer. People can take part if previous treatment was not successful, or no treatment exists. The purpose of this study is to find the highest dose of a medicine called BI 1703880 that people with advanced cancer can tolerate when taken together with ezabenlimab. BI 1703880 and ezabenlimab are medicines that may help the immune system fight cancer. In this study, BI 1703880 is given to people for the first time. Participants get BI 1703880 and ezabenlimab as infusions into a vein. During the first 6 weeks, they get BI 1703880 once a week. Later, they get BI 1703880 every 3 weeks. After the first 3 weeks, they get ezabenlimab in addition every 3 weeks. Participants can get BI 1703880 for up to 1 year and ezabenlimab for up to 2 years as long as they benefit from treatment and can tolerate it. During this time, they visit the study site regularly. At these visits, the doctors check participants' health and take note of any unwanted effects.
Recruiting1 award Phase 114 criteria
BI 907828
for Advanced Cancer
This study is open to adults with different types of advanced cancer (solid tumors). The purpose of this study is to find out the most suitable dose of BI 907828 (brigimadlin) the participants can tolerate. The most suitable dose is used in the second part to find out whether brigimadlin makes tumors shrink. In this study, brigimadlin is given to humans for the first time. Brigimadlin is a so-called MDM2 inhibitor that is being developed to treat cancer. Brigimadlin is taken as a tablet. Participants either take a dose of brigimadlin on one day every 3 weeks or on two days every 4 weeks. The participants are in the study for as long as they benefit from and can tolerate treatment. The doctors regularly check the participants' general health during the study.
Recruiting1 award Phase 1
ABBV-525
for B-Cell Cancers
This trial tests a new drug called ABBV-525 for treating a type of white blood cell cancer. It involves adults with this cancer and aims to find the best dose by giving the drug in different amounts. The study will last several years and requires frequent check-ups.
Recruiting1 award Phase 1
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Yale University School of Medicine?
Yale University School of Medicine is a medical facility located in New Haven, Connecticut. This center is recognized for care of Alzheimer's Disease, Type 1 Diabetes, Diabetes, Cancer, Obesity and other specialties. Yale University School of Medicine is involved with conducting 728 clinical trials across 652 conditions. There are 64 research doctors associated with this hospital, such as Patricia M Lorusso, Alessandro Santin, Amer M. Zeidan, and Charles Matouk.
Where is Yale University School of Medicine located?
To reach Yale University School of Medicine hospital in New Haven, Connecticut, exit I-95 at Exit 47 and follow the Route 34 connector. Enter the Air Rights Garage and proceed to the 4th floor to access the hospital via a bridge. Alternatively, use GPS with the destination address 35 Park Street, New Haven, CT 06519.
Who should I call to ask about financial aid or insurance network?
**Yale University School of Medicine Hospital Financial Assistance:**
- **Office of Financial Aid:** Located at Harkness Building D, ESH 202, 367 Cedar Street, New Haven, CT 06510 USA. For appointments or inquiries, email is available.
- **Billing and Finance:** For insurance-related questions, bill inquiries, coordination of benefits, and premium payments, contact Yale Health's Billing and Finance Department at 866-341-0673. Credit card payments can be made by calling 203-436-8882 or through the online pay portal.
- **Patient Advocacy:** For assistance with issues or complaints, reach out to the Patient Advocacy Department at 1-203-785-2140 or via email at YMPatientAdvocacy@yale.edu.
- **Central Billing Line:** For questions about your bill, call Yale Medicine's Central Billing Line at 1-800-826-9922.
What insurance does Yale University School of Medicine accept?
The Yale University School of Medicine, part of the Yale New Haven Health System, accepts most major managed care and governmental health insurance plans in the Northeast. Patients are advised to directly verify coverage, benefit levels, and any referral or authorization requirements with their health insurance plan. Yale University faculty and staff have access to various medical, dental, and vision plan options, including Yale Health, Aetna medical plans, and Delta Dental, and should review the eligibility requirements and coverage guidelines to select the best plan.
What awards or recognition has Yale University School of Medicine received?
Yale University School of Medicine, along with Yale New Haven Hospital, is renowned for significant contributions to biomedical research and healthcare advancements. They engage in a pioneering collaboration with University College London to enhance global health through translational medicine. Yale School of Medicine is distinguished by its extensive clinical research, including hundreds of annual trials aimed at evaluating new medical treatments' safety and effectiveness.